Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2918 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2018-12-04 | 2019-06-04 | 68589 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2018-12-04 | 2019-06-04 | 68594 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2020-10-08 | 2020-10-15 | 126029 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2020-11-19 | 2021-01-28 | 128597 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2020-12-10 | 2021-01-28 | 129978 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-03-25 | 2021-05-06 | 136292 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-03-04 | 2022-03-24 | 156064 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-08-18 | 2022-10-18 | 167182 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-12-01 | 2022-12-22 | 176821 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2023-02-09 | 2023-06-09 | 184225 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190731 |
| TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-01-25 | 2024-04-25 | 217240 |
| TEVA-DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-02-01 | 2024-04-25 | 218145 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-05-10 | 2017-09-19 | 9901 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2023-04-28 | 61340 |
| ACT DILTIAZEM CD | Actual shortage | 2018-12-04 | 2018-12-04 | 68602 | ||
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-26 | 2021-05-26 | 82552 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-04-26 | 2021-05-26 | 82555 |
| TEVA-DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2017-03-17 | 2018-10-11 | 3362 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2017-08-24 | 2017-10-10 | 20315 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2025-05-27 | 2025-05-27 | 258359 |
| CEFTRIAXONE SODIUM FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258691 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| COUGH SYRUP WITH CODEINE | 30MG 3.3MG 100MG | SYRUP SYRUP | Reversed | 2025-05-28 | 2025-06-03 | 258600 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 |